Emerging Markets: Shifting Environment of Clinical Trials in India

March 25, 2014, Webinar / Online Seminar
KSLS45 nahlad300

RECORDING AVAILABLE NOW

 
Watch the full version of the Emerging Markets: Shifting Environment of Clinical Trials in India webinar.
 

KEYNOTE Recent Updates to CT Regulations in India-A Summary

sreedhar tirunagariSreedhar Tirunagari, Makro Care Clinical Research,
India, Medical Doctor, Clinical research Professional

He has been listed among 100 Most Inspiring People in the Life-Sciences Industry in the year 2012- „Pharma Voice Magazine“ ,Nominated for Clinical trial Innovation - 2nd Annual Partnerships in Clinical Trials Awards Ceremony, USA -2012, Finalist for „SCRIP AWARD -2012“ and Key Opinion Leader-Biowebspin.

The Central Drugs Standard Control Organization (CDSCO) in India has issued number of guidelines to strengthen clinical trial regulations in India after January
2013.

The aforesaid amendments to Schedule Y of the Rules came as a response to demands from the apex court, which were outraged by the lack of supervision and regulation of these clinical trials in India. Also as a response to the public interest litigation(s) filed by few NGOs working for the human rights of the vulnerable sections. The CDSCO and Ministry of Health and Welfare tightened the norms relating to the conduct of clinical trials and also the approval mechanism for such clinical trials.

Have you been wondering what the changes to CT regulations in India are, and unable to find a summary? This webinar will take you through helpful synthesis, including links to numerous resources and articles.

More Details in the Event Brochure

chanakya-patel

Chanakya Patel
Central Drugs Standard Organization (CDSCO), India, Regulatory Affairs and Pharmacovigilance

viraj-rajadhyaksha

Viraj Rajadhyaksha
Astrazeneca, Singapore
Asia Area Medical Affairs Manager

sreedhar tirunagari

Sreedhar Tirunagari
Makro Care Clinical Research, India, Medical Doctor, Clinical research Professional

 

Download PDF Brochure with details about our speakers and their topics.
PDF Agenda
Full Name *
Corporate Email *
Phone number *
 

Join 3 TOP Experts on Clinical Trials in India on March 25

Despite India being a hub of clinical trials for drugs a huge wave of opposition to the practices for conducting clinical trials have raised. Questions are many and the future of the trials is being threatened. To shed light on this rather hazy situation, challenge our speakers and get the cutting-edge information.


Join webinar nowReg here 235x90
for a reduced price:
 
€ 169 € 249

Emerging Markets Webinars: Shifting Environment of Clinical Trials in Ind

Any Questions?

Contact Oana Burghelea

Oana Burghelea
Marketing Manager

Join me on LinkedIn

+421 257 272 156
oana.burghelea@kakushingroup.com

Why to Join a Webinar?
webinar benefits red
Media Partners
pharmavoice
HealthEconomics
pharmaphorum